Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/27869
Title: Rare variant contribution to human disease in 281,104 UK Biobank exomes.
Austin Authors: Wang, Quanli;Dhindsa, Ryan S;Carss, Keren;Harper, Andrew R;Nag, Abhishek;Tachmazidou, Ioanna;Vitsios, Dimitrios;Deevi, Sri V V;Mackay, Alex;Muthas, Daniel;Hühn, Michael;Monkley, Susan;Olsson, Henric;Wasilewski, Sebastian;Smith, Katherine R;March, Ruth;Platt, Adam;Haefliger, Carolina;Petrovski, Slavé
Affiliation: Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK
Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK
Precision Medicine & Biosamples, Oncology R&D, AstraZeneca, Cambridge, UK
Epilepsy Research Centre
Medicine (University of Melbourne)
Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Waltham, MA, USA
Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden..
Issue Date: Sep-2021
Date: 2021-08-10
Publication information: Nature 2021; 597(7877): 527-532
Abstract: Genome-wide association studies have uncovered thousands of common variants associated with human disease, but the contribution of rare variants to common disease remains relatively unexplored. The UK Biobank contains detailed phenotypic data linked to medical records for approximately 500,000 participants, offering an unprecedented opportunity to evaluate the effect of rare variation on a broad collection of traits1,2. Here we study the relationships between rare protein-coding variants and 17,361 binary and 1,419 quantitative phenotypes using exome sequencing data from 269,171 UK Biobank participants of European ancestry. Gene-based collapsing analyses revealed 1,703 statistically significant gene-phenotype associations for binary traits, with a median odds ratio of 12.4. Furthermore, 83% of these associations were undetectable via single-variant association tests, emphasizing the power of gene-based collapsing analysis in the setting of high allelic heterogeneity. Gene-phenotype associations were also significantly enriched for loss-of-function-mediated traits and approved drug targets. Finally, we performed ancestry-specific and pan-ancestry collapsing analyses using exome sequencing data from 11,933 UK Biobank participants of African, East Asian or South Asian ancestry. Our results highlight a significant contribution of rare variants to common disease. Summary statistics are publicly available through an interactive portal ( http://azphewas.com/ ).
URI: https://ahro.austin.org.au/austinjspui/handle/1/27869
DOI: 10.1038/s41586-021-03855-y
ORCID: 0000-0002-8965-0813
0000-0001-5327-0328
0000-0002-0405-4335
0000-0002-5101-8871
0000-0002-3455-1789
0000-0002-5095-5716
0000-0002-1527-961X
Journal: Nature
PubMed URL: 34375979
Type: Journal Article
Appears in Collections:Journal articles

Show full item record

Page view(s)

28
checked on Nov 22, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.